Nicholas Karalis, RPh

Government involvement may be required in order to keep corporate entities from bullying specialty pharmacies out of business.

Who will stand up for the rights of patients when specialty pharmacy benefit decisions based on cost savings and profits negatively affect patient care?

Why are limited distribution networks found only in the United States? Does pharma know best?

If the biggest impact of the ACA will be on Medicare and one of the biggest changes in Medicare is the accountable care organization (ACO) model, then one could argue that ACOs will have the biggest impact on our health care system.

All of the stakeholders agree that patient outcomes is a priority. Why do we allow fragmented patient care, payments, and delivery systems?

Audits are a powerful tool for health care and should be used to measure outcomes and performance. Our columnist share his personal view on what he sees in the current climate.

Working together to contain the cost of expensive specialty medications and provide patients with what they need is the challenge we face in the world of specialty pharmacy.

The challenges for specialty pharmacists that offer comprehensive services in oncology are great. Here's how our columnist sees the problems and opportunities for community specialty pharmacists.

Medication management programs rely on communication between the pharmacy, the patient, and the prescriber. Here are one specialty pharmacist's thoughts on adherence.